We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
(+22%)
Cap. Flow
+$454M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$34.9M |
| 2 |
SBA Communications
SBAC
|
+$31.5M |
| 3 |
Lennox International
LII
|
+$29.1M |
| 4 |
McKesson
MCK
|
+$24.8M |
| 5 |
Cable One
CABO
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$42.5M |
| 4 |
Intuitive Surgical
ISRG
|
+$35.5M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 16.58% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Industrials | 12.36% |
| 5 | Healthcare | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Medpace
MEDP
$16.5B
| $1.85M | 0.03% |
31,296
-68,031
| -68% | -$4.06M |
|
|
CXP
527
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $1.84M | 0.03% |
81,779
+54,000
| +194% | +$1.17M |
|
528
iShares Russell 2000 Value ETF
IWN
$14.4B
| $1.82M | 0.03% |
15,200
-3,000
| -16% | -$358K |
|
529
Liberty Latin America Class C
LILAK
$1.55B
| $1.81M | 0.03% |
108,960
-151,094
| -58% | -$2.35M |
|
530
HealthEquity
HQY
$8.28B
| $1.8M | 0.03% |
24,400
-9,710
| -28% | -$683K |
|
|
SCS
531
DELISTED
Steelcase
SCS
| $1.8M | 0.03% |
123,706
+46,500
| +60% | +$773K |
|
|
AHT
532
Ashford Hospitality Trust
AHT
$20.9M
| $1.78M | 0.03% |
380
-18
| -5% | -$86.8K |
|
|
MIK
533
DELISTED
Michaels Stores, Inc
MIK
| $1.78M | 0.03% |
155,800
-146,210
| -48% | -$2M |
|
534
Cytokinetics
CYTK
$10.9B
| $1.78M | 0.03% |
219,736
+73,500
| +50% | +$540K |
|
535
Adient
ADNT
$1.62B
| $1.78M | 0.03% |
+137,100
| New | +$2.4M |
|
536
Koppers
KOP
$954M
| $1.77M | 0.03% |
68,061
+1,900
| +3% | +$44.7K |
|
537
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
| $1.75M | 0.03% |
5,080
| – | – |
|
538
Curtiss-Wright
CW
$27.5B
| $1.75M | 0.03% |
15,468
+7,590
| +96% | +$864K |
|
539
Great Southern Bancorp
GSBC
$863M
| $1.75M | 0.03% |
33,740
+9,600
| +40% | +$510K |
|
|
DLPH
540
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $1.73M | 0.03% |
89,870
+41,700
| +87% | +$771K |
|
541
Sunstone Hotel Investors
SHO
$2.2B
| $1.72M | 0.02% |
119,350
-76,208
| -39% | -$1.1M |
|
542
Texas Capital Bancshares
TCBI
$4.28B
| $1.72M | 0.02% |
31,420
| – | – |
|
|
FBM
543
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $1.71M | 0.02% |
174,084
+29,031
| +20% | +$281K |
|
544
QCR Holdings
QCRH
$1.65B
| $1.7M | 0.02% |
50,233
+8,500
| +20% | +$292K |
|
|
SNCR
545
DELISTED
Synchronoss Technologies
SNCR
| $1.7M | 0.02% |
31,138
+9,587
| +44% | +$623K |
|
|
VRS
546
DELISTED
Verso Corporation
VRS
| $1.7M | 0.02% |
79,235
+15,300
| +24% | +$353K |
|
547
Puma Biotechnology
PBYI
$407M
| $1.69M | 0.02% |
43,580
+26,040
| +148% | +$795K |
|
548
Crane NXT
CXT
$3.12B
| $1.69M | 0.02% |
57,465
-10,393
| -15% | -$294K |
|
549
SITE Centers
SITC
$232M
| $1.69M | 0.02% |
158,937
+17,304
| +12% | +$175K |
|
550
Magnite
MGNI
$2.73B
| $1.69M | 0.02% |
277,446
-162,484
| -37% | -$836K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2019 Portfolio in Review
As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.
- Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
- Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
- Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
- Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
- Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
- Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.